Nuria Almiñana Domenech

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 10 EPO patents. Top assignees: Lipotec, S.a., Bcn Peptides S.a., Lubrizol Advanced Materials, Inc.. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nuria Almiñana Domenech. Retrieved from https://idiyas.com/inventor/nuria-alminana-domenech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 5

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 120(Granted Patents)

Location History:

Gavá-Barcelona, ES (2016)
Barcelona, ES (2012 - 2020)

Company Filing History:

Lubrizol Advanced Materials, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10799442 - Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes (2020-10-13),

2. 10413501 - Cosmetic composition containing halomonas ferment extract, and use thereof (2019-09-17),

3. 9464129 - Neuronal exocytosis inhibiting peptides (2016-10-11),

4. 9393186 - Synthetic peptides useful in the treatment of the skin and use thereof in cosmetic or dermopharmaceutical compositions (2016-07-19),

5. 9315564 - Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors (2016-04-19),

6. 9266921 - PGC-1α-modulating peptides (2016-02-23),

7. 9067967 - Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions (2015-06-30),

8. 8993716 - Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions (2015-03-31),

9. 8946166 - Peptide-based compounds and compositions which inhibit muscle contraction (2015-02-03),

10. 8710011 - Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp (2014-04-29),

11. 8710010 - Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions (2014-04-29),

12. 8110207 - Pigmentation-regulating compounds (2012-02-07),

Title: The Innovative Mind of Nuria Almiñana Domenech

Introduction

Nuria Almiñana Domenech is a prominent inventor based in Barcelona, Spain, known for her significant contributions to the field of biotechnology and cosmetic science. With a total of eight patents under her name, she has established herself as a key player in developing innovative solutions for skin treatments.

Latest Patents

Nuria's latest patents include groundbreaking inventions related to neuronal exocytosis inhibiting peptides. Her invention pertains to peptides that can regulate neuronal exocytosis, which is crucial for various physiological processes. The peptides are characterized by a general formula and are designed for use in cosmetic and pharmaceutical compositions, specifically aimed at treating conditions requiring neuronal exocytosis regulation, particularly in the skincare domain.

Another notable patent focuses on synthetic peptides that can regulate fibrillogenesis. This invention addresses skin conditions such as aging and the appearance of scars. Her methodologies for obtaining cosmetic or dermopharmaceutical compositions containing these peptides showcase her commitment to advancing skincare treatments.

Career Highlights

Throughout her career, Nuria has worked with reputable companies such as Lipotec S.A. and Bcn Peptides S.A., where she has played a vital role in research and development. Her expertise in peptide technology and cosmetic formulations has propelled her to the forefront of innovation in her field.

Collaborations

In her pursuit of excellence, Nuria has collaborated with esteemed colleagues like Cristina Carreño Serraïma and Wim Van Den Nest. These collaborations have not only enriched her research endeavors but have also fostered an environment of shared knowledge and innovation in the biotechnology sector.

Conclusion

Nuria Almiñana Domenech exemplifies the spirit of innovation through her extensive portfolio of patents and collaborative efforts. Her work continues to make significant strides in the realms of biotechnology and skincare, paving the way for future advancements that enhance the quality of life for many.

Profile summary based on public USPTO records.